Implications of the New NIH Policy on Animal Research for Transplant Science [0.03%]
新NIH动物研究政策对移植科学的影响
Mandy L Ford,Paolo Cravedi
Mandy L Ford
Changes in characteristics of recovered U.S. deceased donor kidneys lead to large changes in KDRI-to-KDPI scaling over time [0.03%]
美国器官共享系统的供肾特征变化导致KDRI和KDPI的转换因子随之改变
Miko E Yu,Syed Ali Husain,Lindsey M Maclay et al.
Miko E Yu et al.
The Kidney Donor Risk Index (KDRI) was introduced into the US kidney allocation system in 2014 as an estimate of the relative risk of post-transplant deceased donor kidney allograft failure in an adult recipient. It is scaled annually relat...
Living Right Liver Donation from Donors Aged 45 and Older: Outcomes for Both Donors and Recipients [0.03%]
右侧活体供肝捐献者年龄在45岁以上：供体和受体的预后研究
Sang-Hoon Kim,Dong-Hwan Jung,Shin Hwang et al.
Sang-Hoon Kim et al.
This study evaluated the safety of living-donor liver transplantation (LDLT) using right lobe (RL) grafts from older donors (ODs; age ≥45 years) compared to younger donors (YDs; age
Increasing the acceptance of thoraco-abdominal normothermic regional perfusion in DCD heart donation: A case for collaborative donor research [0.03%]
提高DCD心脏捐献中胸腹温血区域灌注接受率：合作开展供体研究的必要性
John O Louca,Alex Manara,Ashish Shah et al.
John O Louca et al.
Donation after circulatory death (DCD) transplantation offers an effective and safe method of increasing the number of heart transplants performed. The DCD heart is ischaemic at the time of retrieval and therefore requires reperfusion. This...
Ischemia-Free Liver Transplantation As a Novel Approach to Improve Survival and Clinical Outcomes in the Acute-on-Chronic Liver Failure Scenario [0.03%]
无缺血肝移植改善急性-on-慢性肝功能衰竭预后的临床应用及实验研究
Yunhua Tang,Jiahao Li,Meiting Qin et al.
Yunhua Tang et al.
Acute-on-chronic liver failure (ACLF) is a life-threatening condition with high mortality. Ischemia-free liver transplantation (IFLT), a novel clinical approach avoiding ischemia-reperfusion injury, may offer significant benefits for ACLF p...
Off-Label Use of Alemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation - Long-Term Real-World Experience [0.03%]
人源化单克隆抗体、百利佐米和雷帕霉素在肾移植中的超说明书用药长期真实世界经验
Kateryna Krynychka,Goni Katz-Greenberg,Jennifer S Byrns et al.
Kateryna Krynychka et al.
Conventional immunosuppressive regimens in kidney transplantation continue to pose significant challenges, largely due to their reliance on calcineurin inhibitors (CNI) and corticosteroids. These challenges have driven the search for altern...
2025 Report of the STAR Working Group on Donor Derived Cell Free DNA: Establishing Analytical Validity as the Basis for Appropriate and Effective Clinical Utilization [0.03%]
2025年STAR工作组关于供体来源的细胞游离DNA报告：建立分析有效性作为适当和有效临床应用的基础
Nicole M Valenzuela,James Lan,Kelley M K Hitchman et al.
Nicole M Valenzuela et al.
A working group under the Sensitization in Transplant: Assessment of Risk (STAR) initiative was established in 2023 to develop guidelines for analytic and clinical validity of lab-based testing for donor-derived cell-free DNA (dd-cfDNA). Me...
Trends and Recipient Outcomes in Multiorgan Transplantation in the United States 2013-2023 [0.03%]
2013至2023年美国多器官移植的发展趋势及受者结局
Mason Lai,Elizabeth C Verna,Tomoaki Kato et al.
Mason Lai et al.
Multiorgan transplantation (MOT) in the United States is increasing, but data on the epidemiology and post-transplant outcomes are lacking. Using the SRTR database, we examined annual transplant volume, mortality, and graft failure in adult...
Advancements in Imaging Modalities for Post-Kidney Transplant Monitoring: A Focus on Contrast-Enhanced Ultrasound [0.03%]
肾脏移植后影像学模态的进展：聚焦对比增强超声技术
Sylvain Bodard,Theodore T Pierce,Madeleine Sertic et al.
Sylvain Bodard et al.
Early and accurate detection of post-transplant complications is critical for preserving graft function and optimizing long-term outcomes. While conventional ultrasound is widely used in transplant monitoring, its limitations in assessing m...